Histone deacetylase 2 post-transcriptional end site regulatory RNA (HDAC2 ecRNA)

The HDAC2 post-transcriptional end site ecRNA is a regulatory non-coding RNA molecule that overlaps the 3' polyadenylation site (PAS) of the Histone Deacetylase 2 (HDAC2) gene. This RNA, often classified as a regulatory RNA (regRNA) or enhancer-complementary RNA (ecRNA), acts as a molecular rheostat that controls the transcriptional output and stability of the HDAC2 transcript (Camp4 Therapeutics, 2021). HDAC2 is a Class I histone deacetylase that plays a critical role in the epigenetic repression of genes essential for synaptic plasticity, learning, and memory (Guan et al., 2009). In neurodegenerative conditions such as Alzheimer's disease, HDAC2 is pathologically upregulated, creating an 'epigenetic blockade' that prevents the expression of genes necessary for cognitive function (Gräff et al., 2012). Therapeutic strategies targeting this ecRNA utilize antisense oligonucleotides (ASOs) to bind and induce the degradation of the regulatory RNA. By reducing the levels of this specific ecRNA, the expression of the HDAC2 protein can be precisely downregulated, thereby alleviating the repression of synaptic genes and potentially restoring cognitive function. This approach offers a significant advantage over traditional small-molecule HDAC inhibitors, which often lack isoform selectivity and can cause systemic toxicity. By targeting a gene-specific regulatory RNA, researchers aim to achieve highly localized and specific modulation of HDAC2 without affecting other closely related enzymes like HDAC1.

Other names

HDAC2 regRNAHDAC2 regulatory RNAHDAC2 3' end regulatory RNAHDAC2 enhancer-complementary RNAHDAC2 PAS-overlapping RNA

Antisense oligonucleotide-mediated degradation of the regulatory RNA to downregulate HDAC2 protein expression